triazinate has been researched along with Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banner, RL; Benjamin, RS; Bodey, GP; Burgess, MA; Freireich, EJ; Gutterman, JU; Murphy, WK; Richman, SP; Rodriguez, V; Valdivieso, M | 1 |
| Bertino, JR; Cashmore, AR; Sawicki, WL; Skeel, RT | 1 |
| Blumenschein, GR; Bodey, GP; Burgess, MA; Freireich, EJ; Gottlieb, J; Livingston, R; Rodriguez, V; Spitzer, G; Wheeler, W | 1 |
3 other study(ies) available for triazinate and Neoplasms
| Article | Year |
|---|---|
Phase 2 study with Baker's Antifol in solid tumors.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Carcinoma, Squamous Cell; Colonic Neoplasms; Drug Eruptions; Female; Folic Acid Antagonists; Head and Neck Neoplasms; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Rectal Neoplasms; Remission, Spontaneous; Sarcoma; Stomatitis; Triazines | 1977 |
Inhibition of DNA synthesis in normal and malignant human cells by triazinate (Baker's antifol) and methotrexate.
Topics: Bone Marrow; Bone Marrow Cells; DNA; DNA, Neoplasm; Drug Resistance; Folic Acid Antagonists; Humans; Leukemia; Methotrexate; Neoplasms; Triazines | 1976 |
Phase I studies with Baker's Antifol (BAF) (NSC 139105).
Topics: Adolescent; Adult; Aged; Bone Marrow; Drug Evaluation; Female; Folic Acid Antagonists; Humans; Male; Middle Aged; Neoplasms; Triazines | 1976 |